Micronoma Announcements

Micronoma Makes Key VP of Business Development Hire

Todd Czerwinski will oversee the development and execution of market access, strategic partnerships and sales as the company rolls out its groundbreaking early cancer diagnosis platform SAN DIEGO, May 24, 2022 — Micronoma, the first cancer detection biotech company...

Micronoma Wins Fourth Innovation Award This Year

Microbiome-driven liquid biopsy company draws international recognition for using innovative technology to enable early cancer detection and improve chances of survivalSAN DIEGO, Nov. 3, 2021 /PRNewswire/ -- Micronoma, the first cancer detection biotech company to...

Micronoma Wins Bio-IT World Innovative Practices Award

Machine learning and microbiome-driven liquid biopsy technology draws recognition for improving early cancer diagnosis and chances of survival August 2, 2021 ­­­­– San Diego, Calif. Micronoma, the first cancer detection biotech company to diagnose cancer  at an early...

Micronoma Raises $3.5 Million in Convertible Note Financing

Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 -- San Diego, Calif. Micronoma, the first cancer detection biotech company that utilizes signals from the...

Micronoma Establishes Scientific Advisory Board

International oncology, microbiome and drug discovery expertise synergize to guide unique early cancer detection startup SAN DIEGO, Dec. 9, 2020 /PRNewswire/ -- Micronoma, the first cancer detection biotech company that uses signals from the tumor-related microbiome...

Micronoma Expands Executive Team and Operations

Micronoma Expands Executive Team and Operations

SAN DIEGO, Calif., Nov. 5, 2020 /PRNewswire/ -- Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique microbiome-based assay, today announced their company expansion with three key executive...

Micronoma Expands Executive Team and Operations

Innovative early cancer detection company establishes headquarters and adds three key executive positions San Diego, Calif. (November 5, 2020). Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique...

Micronoma Appoints Magda Marquet Chairman of the Board

Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ -- Micronoma, an early stage cancer-detection start-up seeking to develop and commercialize a minimally-invasive, unique...

Micronoma Launches with $3 Million Seed Funding

For Immediate Release Media Contact: Celia Sepulveda, Celia.Sepulveda@Micronoma.com, 858.337.1326   Micronoma Launches with $3 Million Seed Funding   First early cancer-detection company to use microbial biomarkers in diagnostics   San Diego, Calif....

Website Terms of Use, Privacy Policy, and Licenses

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

Micronoma
6342 Ferris Square
San Diego, CA 92121